3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Stomach Neoplasms
9
Neoplasm Metastasis
7
Esophageal Neoplasms
7
Colorectal Neoplasms
6
Neoplasms
5
HER2-positive Breast Cancer
5
Endometrial Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma Of Esophagus
3
Adenocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Colonic Neoplasms
2
Brain Neoplasms
2
Biliary Tract Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Bevacizumab
4
palbociclib
2
ribociclib
1
repotrectinib
1
olaparib
1
encorafenib
1
durvalumab
1
atezolizumab
1
Tretinoin
1
Paclitaxel
1
Oviposition
1
Leucovorin
1
Irinotecan
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Fulvestrant
1
Fluorouracil
1
Drug Therapy
1
Drainage
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Trastuzumab
×
90 days
×
Clear all
No trials found.